NIFTY  8,924.40  -0.17%
  SENSEX  28,918.50  0.09%
 CURRENCY  Rs  66.83/$ 70.65/€, 83.79/£
  GOLD  29,622.00  -0.00%
  SILVER  43,384.00  0.07%
  DAX  11,804.00  -1.20%
  FTSE  7,243.70  -0.38%
  CAC  4,845.24  -0.79%
  HANG SENG  23,965.70  -0.62%
  NIKKEI  19,283.50  -0.45%
  Shanghai Composite  3,253.43  0.04%
  DOW JONES  20,821.80  0.06%
  NASDAQ  5,845.31  0.17%
  S&P 500  2,367.34  0.15%
LUPIN - Pact To Distribute And Promote Quetiapine Tablets In Japan LUPIN - Astellas And Co's Unit Kyowa Enter Into An Agreement

Strong Q1 On Good Product Mix: Biocon

Video:

Play this video

July 26: After posting a good set of earnings numbers, Biocon Chairman and MD Kiran Mazumdar Shaw says the company’s good product mix, led by the insulin business, has fuelled growth in the first quarter. The research services business also grew 26% in Q1, she adds.